ISSCR Digital Series | Cell Manufacturing
As more stem cell discoveries are translated, the development of products based on these discoveries will depend on solving manufacturing challenges, including the scale-up or scale-out of products to achieve commercial quantities and qualities. This four-part meeting series is aimed at addressing these manufacturing and regulatory challenges to bring promising new cell therapies to the clinic.
Jacqueline Barry, PhD
Catapult Cell and Gene Therapy, UK
Melissa Carpenter, PhD
ElevateBio/Carpenter Group Consulting, USA